TXMD

TherapeuticsMD Inc

TXMD, USA

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

https://www.therapeuticsmd.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
TXMD
stock
TXMD

With TherapeuticsMD Stock Surging, Have You Considered The Downside? Trefis

Read more →
TXMD
stock
TXMD

TherapeuticsMD, Inc. (TXMD) -6.3% in After-hours: Price Decline Despite Recent Results Stocks Telegraph

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$5

Analyst Picks

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Neutral

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very Low

159.00

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very Low

0.78

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

0.55 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

0.39 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

133.42 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.41

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 32.80% of the total shares of TherapeuticsMD Inc

1.

Rubric Capital Management LP

(10.3003%)

since

2025/06/30

2.

Clearline Capital LP

(5.4882%)

since

2025/06/30

3.

Vanguard Group Inc

(3.2745%)

since

2025/06/30

4.

Tejara Capital Ltd

(2.9743%)

since

2025/06/30

5.

Vanguard Total Stock Mkt Idx Inv

(2.1108%)

since

2025/07/31

6.

ADAR1 Capital Management LLC

(1.8075%)

since

2025/06/30

7.

Morgan Stanley - Brokerage Accounts

(1.1336%)

since

2025/06/30

8.

BlackRock Inc

(1.0034%)

since

2025/06/30

9.

Geode Capital Management, LLC

(0.9425%)

since

2025/06/30

10.

Vanguard Institutional Extnd Mkt Idx Tr

(0.7255%)

since

2025/07/31

11.

Fidelity Extended Market Index

(0.5496%)

since

2025/07/31

12.

Bridgeway Capital Management, LLC

(0.2938%)

since

2025/06/30

13.

Bridgeway Ultra-Small Company Market

(0.2938%)

since

2025/06/30

14.

State Street Corp

(0.2601%)

since

2025/06/30

15.

Northern Trust Corp

(0.1422%)

since

2025/06/30

16.

Extended Equity Market Fund K

(0.1365%)

since

2025/06/30

17.

Fidelity Series Total Market Index

(0.1324%)

since

2025/07/31

18.

Renaissance Technologies Corp

(0.1287%)

since

2025/06/30

19.

Fidelity Total Market Index

(0.1282%)

since

2025/07/31

20.

J. Goldman & Co LP

(0.1172%)

since

2025/06/30

21.

TWO SIGMA SECURITIES, LLC

(0.0902%)

since

2025/06/30

22.

Spartan Extended Market Index Pool F

(0.0882%)

since

2025/07/31

23.

NT Ext Equity Mkt Idx Fd - NL

(0.0756%)

since

2025/06/30

24.

FMR Inc

(0.0716%)

since

2025/06/30

25.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0587%)

since

2025/06/30

26.

Fidelity OTC

(0.0585%)

since

2025/07/31

27.

NT Ext Equity Mkt Idx Fd - L

(0.0567%)

since

2025/06/30

28.

Northern Trust Extended Eq Market Idx

(0.0567%)

since

2025/06/30

29.

Vanguard Instl Ttl Stck Mkt Idx Tr

(0.0474%)

since

2024/12/31

30.

Spartan Total Market Index Pool G

(0.0435%)

since

2025/07/31

31.

Vanguard U.S. Eq Idx £ Acc

(0.0427%)

since

2025/07/31

32.

UBS Group AG

(0.0389%)

since

2025/06/30

33.

State St US Extended Mkt Indx NL Cl C

(0.0311%)

since

2025/08/31

34.

Gabelli ABC AAA

(0.0259%)

since

2025/03/31

35.

Tower Research Capital LLC

(0.0249%)

since

2025/06/30

36.

Extended Equity Market Fund M

(0.0172%)

since

2025/06/30

37.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.016%)

since

2025/06/30

38.

Advisor Group Holdings, Inc.

(0.0074%)

since

2025/06/30

39.

Bank of America Corp

(0.0045%)

since

2025/06/30

40.

SIMPLEX TRADING, LLC

(0.0037%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

0

EPS Estimate

0

EPS Difference

0

Surprise Percent

null%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(8)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(8.8)
GARP
Fair GARP(4)
Growth
Weak Growth Prospect(3)
Momentum
Strong Momentum(8)
Net Net
Possible Net-Net(4.5)
Quality
Moderate Quality(6)
Value
Fair Value(6)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.